PCAS Group’s Consolidated Turnover Decreases in 2023, with Pharmaceutical Synthesis Activity Showing Slight Growth

© AOF

Legal warning

The AOF information reproduced on Capital.fr is taken from the AOF information service. This information is protected by intellectual property rights held by OPTION FINANCE SAS, publisher of the AOF real-time stock market information service, and its contributors. Consequently, any reproduction, copy, duplication, modification, transfer, rebroadcast, translation, commercial exploitation or not, creation of a hypertext link or reuse in any manner whatsoever of this information is subject to the prior written agreement of OPTION FINANCE SAS and its contributors. AOF can be reached at the following address [email protected] OPTION FINANCE SAS collects its data from the sources it considers the safest. However, subject to gross negligence, OPTION FINANCES SAS and its contributors do not in any way guarantee the absence of errors and defects, even hidden ones, nor the exhaustive nature or lack of conformity for any use of this data and of OPTION FINANCE SAS or one of its contributors, and cannot be held responsible for delays or interruptions which could affect access to the latter. The user of the OPTION FINANCE SAS service will use AOF data at his own risk and must hold OPTION FINANCE SAS and its contributors harmless from any claim resulting from this use.